I was there when: AI dominated chess

Commentator 2: Deep blue! Kasparov, after the C4 move, has resigned! [Applause] Jennifer: I’m Jennifer Strong, and this is i was there when—an oral history project presenting the stories of breakthroughs and defining moments in AI and computing, as told by those who witnessed them. In this episode, we meet the man on the other …

Read More…

400 hp is good, more sharpness would be better

nissan z Full Overview advantage throwback style More power than before is always better comfortable ride cons Heavier, and you feel it boring answers Nothing as refined as Supra When Nissan finally redesigned its Z sports car this year, the bar for the 370Z replacement had dropped mere microns off the ground. The old Z …

Read More…

Togo review: A gritty and underwhelming character study

Loading JustWatch data… Summary Caetano’s gritty character study has a stoic and effective twist from Diego Alsono. If only To carry outThe third act of was not such a disappointing conclusion. This Netflix movie review Togo (2022) is spoiler free. Netflix continues to offer a buffet of movies from around the world: the latest news …

Read More…

Volvo S90 – Used Car Review

VOLVO has been at the forefront of self-driving car and truck development for a few years now and everything it has learned is incorporated into its flagship S90 sedan so that it can sometimes steer, brake and accelerate without driver intervention. Whereas earlier in its life petrol and diesel models were available plus a petrol/electric …

Read More…

Former police officer to go on trial for shooting death

A former police officer accused of fatally shooting Thomas “TJ” Siderio, a 12-year South Philadelphia resident, will go to trial on all charges, a judge ruled this week. Edsaul Mendoza will face first-degree murder charges, among others, in connection with Siderio, who was allegedly shot in the back and killed on March 1 near Barry …

Read More…

Allogene Therapeutics (ALLO) Initiates Industry’s First Allogeneic CAR T Phase 2 Trial

News and research before hearing about it on CNBC and others. Request your 1-week free trial to Street Insider Premium here. Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced the start of ALLO’s potentially pivotal Phase 2 clinical trial. -501A …

Read More…